Skip Navigation

Faculty Directory

Robert Bollinger, MD

  • Professor

Departmental Affiliations

  • School of Medicine (Primary)
  • International Health (Joint)
    • Division: Global Disease Epidemiology and Control

Center & Institute Affiliations

Contact Information

600 N. Wolfe Street
Phipps 540-A
Baltimore, Maryland 21287

410-614-0936

Hopkins Center for Clinical Global Health Education

View Current Courses

Education

MPH, Johns Hopkins Bloomberg School of Public Health, 1988
MD, Dartmouth Medical School, 1984

Overview

Dr. Bollinger is the Raj and Kamla Gupta Professor of Infectious Diseases at the Johns Hopkins University (JHU) School of Medicine, and he holds joint appointments in International Health at the Johns Hopkins (JH) Bloomberg School of Public Health, and in Community Public Health at the JH School of Nursing. He is Founding Director of the Center for Clinical Global Health Education (CCGHE) and Associate Director for Medicine of the Johns Hopkins Center for Global Health. He is board certified by the American Board of Internal Medicine in internal medicine and infectious diseases.

Dr. Bollinger has more than 40 years of experience in international public health, clinical research, and education dealing with such global health priorities as HIV/AIDS, malaria, tuberculosis, leprosy, dengue, antibiotic resistant infections and other emerging diseases. His research interests include identifying biological and behavioral risk factors for HIV transmission; characterizing the clinical progression and treatment of HIV and related infections; development/evaluation of novel point-of-care diagnostics and implementation of research projects to optimize healthcare capacity and delivery in resource-limited settings. Working with partners in more than 20 countries, Dr. Bollinger and CCGHE faculty pioneered the development and use of distance learning and the award-winning emocha mobile health platform. He has been invited to participate in public health training programs and expert committees in more than 15 countries. He is former Director of the JHU Fogarty India Program, and he served as a member of the US Presidential Advisory Council for HIV/AIDS (PACHA), the PACHA International Sub-committee, the Institute of Medicine Forum on Public-Private Partnerships for Global Health and Safety, and the NIH Fogarty International Center Advisory Board.

Dr. Bollinger is committed to improving the health of people living in resource-limited communities through clinical research, education, and leadership training. He established health research and education programs in countries throughout Africa, South and Central America, Southeast Asia, and the Middle East. In 1991, he initiated an NIH-funded Indo-US HIV research program in Pune, India, involving the National AIDS Research Institute/ICMR and the BJ Government Medical College. He has served as Principal Investigator for many NIH-supported studies and clinical trials in Pune, including the SWEN study, which led to changes in World Health Organization (WHO) guidelines for treatment of infants born to HIV positive mothers to prevent mother-to-child transmission. Under his 26 years as leader of the Hopkins India Fogarty International Research Training Program, short-term and degree training has been provided to more than 140 visiting Indian scientists at JHU, and in-country training has been provided to more than 2,000 Indian scientists. His commitment to education has been honored with the Johns Hopkins Department of Medicine David M. Levine Excellence in Mentoring Award.

Dr. Bollinger is author of more than 200 peer-reviewed research publications and 15 book chapters, including the first and largest studies of risk factors for HIV transmission in India, the cloning and sequencing of the first HIV viruses from India, the only studies characterizing the primary immune response to HIV in India, and the demonstration of increased risk of HIV acquisition with recent HSV infection and lack of circumcision.

Dr. Bollinger received an undergraduate degree from Haverford College, a Doctor of Medicine from Dartmouth Medical School, and a Master of Public Health from JH Bloomberg School of Public Health. He completed his internal medicine training at the University of Maryland Medical Systems, followed by a post-doctoral fellowship in infectious diseases at JHU School of Medicine.

Honors and Awards

2007 Center for Clinical Global Health Education (CCGHE), Computerworld Honors Program Laureate in Healthcare

2008 CCGHE, Rich Media Impact Award, Sonic Foundry

2008 Lawrence Forman Award, Haverford College

2009 David M. Levine Excellence in Mentoring Award, Johns Hopkins University School of Medicine

2009 The electronic Mobile Open-Source Comprehensive Health Application (eMOCHA), Finalist, Vodafone Wireless Innovation Award

2010 Honorary Doctorate, Haverford College

2018 Inaugural Recipient of the Raj and Kamla Gupta Professor of Infectious Diseases, Johns Hopkins University

  • Global health workforce education and capacity building
  • Human Immunodeficiency Virus
  • International Health
  • Tuberculosis
  • Public Health
  • Tropical Medicine
  • mobile health
  • point-of-care diagnostics
  • India
  • Ethiopia
  • Uganda
  • South Africa
  • emocha
  • miDOT
  • miLAB

Selected publications from the past year

  • Dhumal, G., Deluca, A., Chandanwale, A., Kadam, D., Joshi, S., Kinikar, A., Gupte, N., Mave, V., Gupta, A., Suryavanshi, N., & Bollinger, R. C. (2020). Impact of the fogarty training program on trainee and institutional research capacity building at a government medical college in India. Annals of global health, 86(1), 1-11. [86]. https://doi.org/10.5334/aogh.2932
  • Paradkar M, Padmapriyadarsini C, Jain D, Shivakumar SVBY, Thiruvengadam K, Gupte AN, Thomas B, Kinikar A, Sekar K, Bharadwaj R, Dolla CK, Gaikwad S, Elilarasi S, Lokhande R, Reddy D, Murali L, Kulkarni V, Pradhan N, Hanna LE, Pattabiraman S, Kohli R, Rani S3, Suryavanshi N, Shrinivasa BM, Cox SR, Selvaraju S, Gupte N, Mave V, Gupta A, Bollinger RC, for the CTRIUMPH-RePORT India Study Team^. Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India. PloS ONE 2020, 15(7) e0236743. https://doi.org/10.1371/journal.pone.0236743
  • Suryavanshi N, Kadam A, Kanade A, Gupte N, Gupta A, Bollinger R, Mave V, Shankar A. Acceptability and feasibility of a behavioral and mobile health intervention (COMBIND) shown to increase uptake of prevention of mother to child transmission (PMTCT) care in India. BMC Public Health (2020) 20:752. https://doi.org/10.1186/s12889-020-08706-5. PMID: 32448299
  • Kamba PF, Mulangwa J, Kaggwa1 B, Kitutu FE, Sewankambo NK, Katabira ET, Byakika Kibwika P, Adome RO, Bollinger RC. Compliance of private pharmacies in Uganda with controlled prescription drugs regulations: a mixed-methods study. Substance Abuse Treatment, Prevention and Policy. 2020; 15:16. https://doi.org/10.1186/s13011-020-00261-x. PMID: 32070374
  • Bollinger RC, Thio CL, Sulkowski MS, McKenzie-White J, Thomas DL, Flexner C. Addressing the Global Burden of Hepatitis B Virus while Developing Long-Acting Injectables for Prevention and Treatment of HIV. The Lancet HIV. December 20, 2019. https://doi.org/10.1016/S2352-3018(19)30342-X. PMID: 31870675. PMCID 7376366.